Cargando…
Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?
OBJECTIVES: Systemic sclerosis (SSc) is a connective tissue disease associated with significant morbidity and mortality and generally inadequate treatment. Endothelial cell activation and apoptosis are thought to be pivotal in the pathogenesis of this disease, but the mechanisms that mediate this re...
Autores principales: | Barnes, Theresa C, Spiller, David G, Anderson, Marina E, Edwards, Steven W, Moots, Robert J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015068/ https://www.ncbi.nlm.nih.gov/pubmed/21068092 http://dx.doi.org/10.1136/ard.2010.133587 |
Ejemplares similares
-
Relative α(1)-anti-trypsin deficiency in systemic sclerosis
por: Barnes, Theresa C., et al.
Publicado: (2011) -
The Many Faces of Interleukin-6: The Role of IL-6 in Inflammation, Vasculopathy, and Fibrosis in Systemic Sclerosis
por: Barnes, Theresa C., et al.
Publicado: (2011) -
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis
por: Denton, Christopher P, et al.
Publicado: (2018) -
Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling
por: Wei, L-H, et al.
Publicado: (2007) -
Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis
por: Nishide, Masayuki, et al.
Publicado: (2017)